Author: Carli Wischhoff
-
Yamicc Explained: Why rare cancers need a different approach
Why rare cancers need a different approach One in two people get cancer.One in five cancer patients is diagnosed with a rare form of the disease. But while oncology has advanced rapidly, traditional research models still fall short for rare cancer patients, because they weren’t built for this kind of complexity. Rare cancers are often…
-
Yamicc Explained: Why we’re building what we’re building
In recent decades, treatment and research in oncology have made huge strides. But for people with a rare form of cancer, survival chances still lag far behind. Finding effective treatments is one of the hardest challenges in these cancers, and not just because of biology. It’s a systemic issue.Patient numbers are low, collaboration is limited,…
-
Glioblastoma Awareness Week
Glioblastoma is a rare and aggressive brain tumour with very limited treatment options, and far too little progress. At Yamicc, we work to change that: for patients and their loved ones, hope and time is everything. As part of our mission in finding more effective treatments for rare cancers, we support the ReDiReCCT-GB trial. This…